Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
ConclusionThese data from our pilot study on a small cohort of SSc patients are the first to demonstrate that treatment with MMF can improves exercise tolerance and leg discomfort in patients with SSc-ILD. These preliminary results need to be confirmed in large randomized studies.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Autoimmune Disease | Carbon Monoxide Poisoning | Cardiology | CT Scan | Heart | Interstitial Lung Disease | Respiratory Medicine | Rheumatology | Scleroderma | Skin | Sports Medicine | Study